SAN CARLOS, Calif. and WASHINGTON, July 30, 2021 /PRNewswire/ — GO2 Foundation for Lung Cancer (GO2 Basis) will current Heather Wakelee, M.D. with the 2021 Bonnie J. Addario Lectureship Award on the Physicians’ Schooling Useful resource® 22nd Annual Worldwide Lung Most cancers Congress on Friday, July 30 in Huntington Seaside, California. Dr. Wakelee is a Professor of Drugs and Chief of the Division of Oncology at Stanford College and Deputy Director of the Stanford Most cancers Institute.
GO2 Basis is recognizing Dr. Wakelee for her a long time of dedication to lung most cancers analysis overlaying a number of aspects of the illness. Dr. Wakelee’s analysis has targeted on many particular lung most cancers subtypes outlined by particular mutations in EGFR, ALK, ROS1, RET, BRAF and others. She has led quite a few scientific trials targeted on lung most cancers remedy, most notably therapies to enhance remedy for sufferers with lung most cancers who’ve undergone surgical procedure (adjuvant remedy). She has additionally collaborated with colleagues on work to raised perceive why lung most cancers develops and higher strategies for detection of lung most cancers.
Lung most cancers is the leading cause of cancer death within the U.S., taking extra lives yearly than colon, breast and prostate cancer combined. Lung most cancers can be the leading cause of cancer death among women in the United States, with the illness anticipated to assert the lives of greater than 62,000 girls in 2021 alone. Roughly, two-thirds of the sufferers who develop lung most cancers who’ve by no means smoked are women. Regardless of this prevelance and better variety of annual deaths, lung cancer is the least funded of the key cancers affecting girls.
“Given girls are disproportionately impacted by lung most cancers, the developments in lung most cancers analysis by girls like Dr. Wakelee are extremely significant to the lung most cancers neighborhood. With GO2’s concentrate on advancing world-class, patient-centered lung most cancers analysis in our mission to avoid wasting, prolong, and enhance the lives of these in danger and recognized with lung most cancers, we’re happy to honor Dr. Wakelee for her dedication to and management on a broad vary of cutting-edge lung most cancers analysis tasks and scientific trials,” stated Bonnie J. Addario, co-founder and chair of GO2 Basis.
“Dr. Wakelee is nationally and internationally acknowledged for her accomplishments in lung most cancers analysis and scientific trial management, however much more in order a visionary with distinctive perception into future instructions for advancing our understanding and administration of this most cancers,” stated Dr. David Gandara, Director of Thoracic Oncology at U.C. Davis Well being and previous Lectureship Award recipient. “Her work, together with her ASCO 2021 landmark presentation on post-operative immunotherapy will result in more practical and hopefully healing remedy s to enhance lung most cancers survivorship, a purpose all of us share and work collectively to realize.”
Dr. Wakelee is a graduate of Princeton College and Johns Hopkins College College of Drugs and accomplished her post-graduate coaching at Stanford College. She serves as Stanford Principal Investigator and on the Govt for the Eastern Cooperative Oncology Group (ECOG-ACRIN), and Fellow of the American Society of Clinical Oncology (FASCO). Her work in immunotherapy of thoracic malignancies contains participation in a number of part III trials of PD-(L)1 checkpoint inhibitors in superior stage NSCLC and extra lately, involvement on steering committees for 2 part III worldwide trials exploring immune checkpoint inhibitors within the peri-operative interval. She actively collaborates with many fundamental scientists at Stanford College searching for to raised perceive molecular and different biomarkers of immune response.
Dr. Wakelee is lively in a number of nationwide and worldwide lung most cancers analysis organizations and is a long-time member, present Board Member and President-Elect of the International Association for the Study of Lung Cancer (IASLC). She has served the IASLC in lots of different capacities together with as chair of the communications committee, co-chair of the thoracic committee, govt committee member and as a member of the Board of Regents.
Dr. Wakelee’s experience and expertise has led her to creator or co-author over 200 medical articles on lung most cancers and different thoracic malignancies.
Previous Bonnie J. Addario Lectureship Award recipients embrace:
- 2020 – Charles Swanton, M.D., Ph.D., FRCP, FMedSci, FRS senior group chief on the Francis Crick Institute
- 2019 – Solange Peters, M.D., Head of Medical Oncology and Chair of Thoracic Oncology on the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland
- 2018 – Vassiliki A. Papadimitrakopoulou, M.D., Chief of Thoracic Medical Oncology, Division of Thoracic/Head and Neck Medical Oncology, College of Texas MD Anderson Most cancers Middle
- 2017 – Frances A. Shepherd, M.D., FRCPC, Senior Workers Doctor, Princess Margaret Most cancers Centre; Professor of Drugs, College of Toronto School of Drugs
- 2016 – Giorgio Vittorio Scagliotti, M.D., Professor of Oncology, College of Torino; Head of the Division of Oncology and Chief of the Division of Medical Oncology, San Luigi Hospital, Torino, Italy
- 2015 – Fred R. Hirsch, M.D., Ph.D., Professor of Drugs, College of Colorado College of Drugs
- 2014 – Roy S. Herbst, M.D., Ph.D., Ensign Professor of Drugs and Chief of Medical Oncology, Yale Most cancers Middle
- 2013 – Tony Mok, M.D., Professor within the Division of Scientific Oncology, Chinese language College of Hong Kong,Prince of Wales Hospital in Hong Kong
- 2012 – D. Ross Camidge, M.D., Ph.D., Director of the Thoracic Oncology Scientific Program and Affiliate Director for Scientific Analysis, Colorado College Most cancers Middle
- 2011 – William Pao, M.D., Ph.D., Affiliate Professor of Drugs, Ingram Affiliate Professor of Most cancers Analysis; Director, Customized Most cancers Drugs, Vanderbilt Ingram Most cancers Middle
- 2010 – David R. Gandara, M.D., Affiliate Director, Scientific Analysis, UC Davis Most cancers Middle
- 2009 – Harvey Move, M.D., B.A., Director of the Division of Thoracic Surgical procedure and Chief of Thoracic Surgical procedure, New York College Medical Middle
- 2008 – Paul A. Bunn, Jr. M.D., Principal Investigator and Director, College of Colorado Most cancers Middle
About GO2 Basis for Lung Most cancers
Based by sufferers and survivors, GO2 Foundation for Lung Cancer transforms survivorship because the world’s main group devoted to saving, extending, and enhancing the lives of these susceptible, in danger, and recognized with lung most cancers. We work to alter the truth of residing with lung most cancers by ending stigma, rising private and non-private analysis funding, and guaranteeing entry to care.
Concerning the Worldwide Lung Most cancers Congress®
For 22 years, Physicians’ Schooling Useful resource® (PER®) International Lung Cancer Congress® has introduced collectively medical, surgical, and radiation oncologists to foster consciousness of state-of-the-art therapies for sufferers with lung most cancers. This 12 months’s two-day digital webcast options cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer periods from main worldwide and nationwide consultants. School share their views and private experiences on the scientific challenges and ongoing controversies in lung most cancers administration.
About Physicians’ Schooling Useful resource®, LLC (PER®)
Since 1995, PER® has been devoted to advancing most cancers care by way of skilled schooling and now advances affected person care and remedy methods on all kinds of power sicknesses and illnesses. In 2016, PER® initiated persevering with medical schooling (CME) programming within the cardiovascular and endocrinology areas. Whereas increasing into subjects exterior of oncology, PER® stands because the main supplier of reside, on-line, and print CME actions associated to oncology and hematology. The high-quality, evidence-based actions function main distinguished consultants who concentrate on the applying of practice-changing advances. PER® is accredited by the Accreditation Council for Persevering with Medical Schooling and the California Board of Registered Nursing. PER® is a model of MJH Life Sciences™, the most important privately held, impartial, full-service medical media firm in North America devoted to delivering trusted well being care information throughout a number of channels.
The International Association for the Study of Lung Cancer (IASLC) is the one international community devoted to the research and eradication of lung most cancers and different thoracic malignancies. Since its founding in 1974, the affiliation’s membership has grown to greater than 8,000 lung and thoracic most cancers specialists from all disciplines and greater than 100 international locations. By internet hosting international conferences, funding cutting-edge analysis, and educating the well being care neighborhood and the general public about thoracic cancers, the IASLC works to alleviate the burden lung most cancers locations on sufferers, households, and communities.
View authentic content material to obtain multimedia:https://www.prnewswire.com/news-releases/go2-foundation-for-lung-cancer-to-honor-heather-wakelee-md-with-the-2021-bonnie-j-addario-lectureship-award-301344810.html
SOURCE GO2 Basis for Lung Most cancers